<DOC>
	<DOC>NCT01427387</DOC>
	<brief_summary>A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending dose of ASP0456 in non-elderly healthy subjects. Two dosing condition, pre-prandial and postprandial administrations, is compared.</brief_summary>
	<brief_title>A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy, as judged by the investigator/subinvestigator based on the results of physical examination and all tests obtained Body weight (at screening); female ≥40.0 kg,&lt;70.0 kg male ≥50.0 kg,&lt;80.0 kg BMI(at screening): ≥17.6,&lt;26.4 Received any investigational drugs in other clinical or postmarketing studies within 120 days before the study Donated 400 mL of whole blood within 90 days, 200 mL of whole blood within 30 days, or blood components within 14 days before the study Received medication within 10 days before dose is administered or is scheduled to receive medication History of drug allergies Upper (e.g. nausea, vomiting, stomachache) and lower (e.g. abdominal pain) gastrointestinal disease within 7 days before the study Concurrent or previous hepatic disease Concurrent or previous heart disease Concurrent or previous renal disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>ASP0456</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>food effect</keyword>
</DOC>